rs6041

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_019616.4(F7):​c.740-20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,579,270 control chromosomes in the GnomAD database, including 12,714 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1211 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11503 hom. )

Consequence

F7
NM_019616.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.77

Publications

22 publications found
Variant links:
Genes affected
F7 (HGNC:3544): (coagulation factor VII) This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
F7 Gene-Disease associations (from GenCC):
  • congenital factor VII deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet, Ambry Genetics
  • factor VII deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-113118393-G-A is Benign according to our data. Variant chr13-113118393-G-A is described in ClinVar as Benign. ClinVar VariationId is 255221.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.262 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F7NM_019616.4 linkc.740-20G>A intron_variant Intron 7 of 7 ENST00000346342.8 NP_062562.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F7ENST00000346342.8 linkc.740-20G>A intron_variant Intron 7 of 7 1 NM_019616.4 ENSP00000329546.4
F7ENST00000375581.3 linkc.806-20G>A intron_variant Intron 8 of 8 1 ENSP00000364731.3
F7ENST00000541084.5 linkc.554-20G>A intron_variant Intron 5 of 5 2 ENSP00000442051.2

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17979
AN:
152092
Hom.:
1203
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.128
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.117
Gnomad ASJ
AF:
0.204
Gnomad EAS
AF:
0.0474
Gnomad SAS
AF:
0.274
Gnomad FIN
AF:
0.0696
Gnomad MID
AF:
0.184
Gnomad NFE
AF:
0.109
Gnomad OTH
AF:
0.136
GnomAD2 exomes
AF:
0.130
AC:
29605
AN:
227000
AF XY:
0.139
show subpopulations
Gnomad AFR exome
AF:
0.130
Gnomad AMR exome
AF:
0.105
Gnomad ASJ exome
AF:
0.191
Gnomad EAS exome
AF:
0.0503
Gnomad FIN exome
AF:
0.0718
Gnomad NFE exome
AF:
0.115
Gnomad OTH exome
AF:
0.134
GnomAD4 exome
AF:
0.117
AC:
166410
AN:
1427060
Hom.:
11503
Cov.:
32
AF XY:
0.122
AC XY:
86367
AN XY:
705972
show subpopulations
African (AFR)
AF:
0.130
AC:
4323
AN:
33142
American (AMR)
AF:
0.108
AC:
4730
AN:
43922
Ashkenazi Jewish (ASJ)
AF:
0.191
AC:
4725
AN:
24746
East Asian (EAS)
AF:
0.0600
AC:
2355
AN:
39250
South Asian (SAS)
AF:
0.277
AC:
23041
AN:
83196
European-Finnish (FIN)
AF:
0.0747
AC:
3148
AN:
42132
Middle Eastern (MID)
AF:
0.212
AC:
1204
AN:
5666
European-Non Finnish (NFE)
AF:
0.105
AC:
115525
AN:
1095848
Other (OTH)
AF:
0.124
AC:
7359
AN:
59158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
8517
17035
25552
34070
42587
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4356
8712
13068
17424
21780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.118
AC:
18009
AN:
152210
Hom.:
1211
Cov.:
33
AF XY:
0.119
AC XY:
8822
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.128
AC:
5326
AN:
41532
American (AMR)
AF:
0.117
AC:
1783
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.204
AC:
708
AN:
3464
East Asian (EAS)
AF:
0.0475
AC:
245
AN:
5162
South Asian (SAS)
AF:
0.274
AC:
1324
AN:
4826
European-Finnish (FIN)
AF:
0.0696
AC:
739
AN:
10612
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.109
AC:
7388
AN:
67996
Other (OTH)
AF:
0.134
AC:
284
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
838
1676
2515
3353
4191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
1851
Bravo
AF:
0.121
Asia WGS
AF:
0.160
AC:
556
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.8
DANN
Benign
0.80
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6041; hg19: chr13-113772707; COSMIC: COSV60645541; COSMIC: COSV60645541; API